Index · 1 ranked
Funds Tracking the NYSE Biotechnology
Ranked by expense ratio, lowest first.
Data as of May 31, 2026 ·How this data is built
As of May 31, 2026, FundVersus ranks 1 funds tracking the NYSE Biotechnology by expense ratio. The lowest is iShares Biotechnology ETF (IBB) at 0.44%. The median is 0.44%; weighted by assets, 0.44%.
Facts from SEC filings. Not investment advice.
The ranking
Only the stated measure sets the order. Expense ratios from prospectuses; net assets and returns from Form N-PORT.
| # | Fund | Expense ratio | Net assets | 1-year return | |
|---|---|---|---|---|---|
| 1 | iShares Biotechnology ETFIBB · ETF · Health Care | 0.44% | $8.1B | +32.36% |
Questions
How is this list ranked?
Ranked by expense ratio, lowest first. It includes funds tracking the NYSE Biotechnology with a current SEC filing and enough data for a FundVersus page. The ranking uses one stated measure and is not a recommendation.
Which has the lowest expense ratio?
iShares Biotechnology ETF (IBB), at 0.44% as of May 31, 2026.
How much money is in these funds?
The 1 funds on this list reported $8.1B in combined net assets on their latest filings.